# US 6,073,048 A · Baroreflex modulation with carotid sinus nerve stimulation for the treatment of heart failure > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 6,073,048 A - Document ID: US6073048A - Status: Granted - Kind: A - Application number: 08/559,957 - Filed: 1995-11-17 - Granted: 2000-06-06 - Earliest claimed: 1995-11-17 - Assignees: Medtronic, Inc. - Inventors: Robert S. Kieval; Tom D. Bettett; Stephanie Michele Fitts - Web page: https://patentgrep.com/patent/US6073048A ## CPC - A61N 1/36564: {controlled by blood pressure} - A61N 1/36114: {Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362)} - A61N 1/36557: {controlled by chemical substances in blood} - A61N 1/36117: {for treating hypertension} - A61N 1/3627: {for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy} - A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B) ## Abstract A system and method for stimulating the baroreflex arc based on levels of indicators from the body includes a pacemaker for bradycardia support pacing should the indicators show the need for support pacing. Other indicators and a process take advantage of an assumed relationship between peripheral vascular resistance and pulmonary resistance to determine the level of nerve stimulation required. This level is adjusted or optimized based on its interaction with heart activity and changes in the other indicators. These other indicators are readily available to the implanted device and allow for a process to make an estimate of pulmonary vascular resistance, from which SVR is also estimated. The value determined for SVR is the primary value used to determine the level of nerve stimulation absent indicators for the need to provide bradicardia pacing. The pacemaker can be rate responsive, as can the process for determining the level of nerve stimulation to be delivered. Several different lead configurations are described. ## Claims ### Claim 1 A system for coordinating the stimulation of nerves for controlling the level of neurohormonal activation in a living body having a heart subject to potential or actual pathologic stress levels comprising: an implantable pulse generator with a microprocessor and memory adapted and disposed to run a plurality of processes, a sensor for sensing SVO.sub.2 in the body, and a sensor for determining pressure in a ventricle of the heart of the body, both said sensors adapted and disposed to provide readings to said microprocessor for use by said processes, a bradycardia pacer control process included within said pulse generator for pacing the heart when a condition of bradycardia is present so as to prevent insufficient heart rate by said heart, at least one stimulation electrode connected to effectively deliver electrical stimulation to a baroreceptor nerve site, an adjustment process for monitoring heart rate and estimating PVR from said SVO.sub.2 and pressure so as to determine appropriate modifications to the stimulation output to said stimulation electrode, and means for making said modifications. ### Claim 2 (depends on 1) A system as set forth in claim 1 wherein said pulse generator comprises a pacing lead in an atrium and in a ventricle of the heart. ### Claim 3 (depends on 1) A system as set forth in claim 1 wherein said pulse generator comprises separate pacing leads in the atrium and the ventricle. ### Claim 4 (depends on 1) A system as set forth in claim 1 wherein said pulse generator comprises an activity sensor associated therewith which provides data on cardiac demand to said pacer control process. ### Claim 5 (depends on 1) A system as set forth in claim 1 wherein said pulse generator has an activity sensor associated therewith which provides data on cardiac demand to said pacer adjustment process. ### Claim 6 (depends on 1) A system as set forth in claim 1 wherein said sensor for determining pressure provides an indication of sensed absolute pressure. ### Claim 7 A system for coordinating the stimulation of nerves for controlling the level of neurohormonal activation in a living body having a heart subject to potential or actual pathologic stress levels comprising: an implantable pulse generator with a microprocessor and memory adapted and disposed to run a plurality of processes, a sensor for sensing and measuring the value of an indicator of SVR in said body, adapted and disposed to provide readings to said microprocessor for use by said processes, a bradycardia pacer control process included within said pulse generator for pacing the heart when a condition of bradycardia is present so as to prevent insufficient heart rate by said heart, at least one stimulation electrode connected to effectively deliver electrical stimulation output to a baroreceptor nerve site, a process for monitoring heart rate and estimating SVR from said sensor in order to modify said stimulation output. ### Claim 8 (depends on 7) A system as set forth in claim 7 wherein said indicator for determining SVR is right ventricular pressure. ### Claim 9 (depends on 7) A system as set forth in claim 7 wherein said indicator for determining SVR is SVO.sub.2. ### Claim 10 (depends on 7) A system as set forth in claim 7 wherein said indicator for determining SVR is a combination of SVO.sub.2 and right ventricular pressure. ### Claim 11 (depends on 10) A system as set forth in claim 10 wherein said process for estimating SVR bases that estimate on the relationship of SVR to PVR and determines PVR based on measured SVO.sub.2 and right ventricular pressure. ### Claim 12 (depends on 7) A system as set forth in claim 7 wherein said process for estimating SVR increases said stimulation output at a predetermined level of estimated SVR and decreases said stimulation output at another predetermined level of estimated SVR. ### Claim 13 (depends on 12) A system as set forth in claim 12, further comprising an activity sensor, wherein said process for estimating SVR comprises a check of the activity sensor level made before increasing said stimulation output. ### Claim 14 (depends on 12) A system as set forth in claim 12 further comprising an additional process within said pulse generator wherein if the estimated SVR is not determined to be above a predetermined level nor below another predetermined level, said additional process determines whether pacing is needed, and if so provides for a decreased amount of said stimulation output. ### Claim 15 (depends on 7) A system as set forth in claim 7 wherein if said activity sensor indicates strenuous exercise, said stimulation output is suspended for the duration such indication is present. ### Claim 16 (depends on 7) A system as set forth in claim 7 further comprising an intracardiac electrode and an additional process within said pulse generator, wherein said additional process provides that said stimulation output is gated to electrocardiographic indicators of cardiac activity received by said intracardiac electrode. ### Claim 17 (depends on 16) A system as set forth in claim 16 wherein said additional process provides comprises variable stimulation output settings and delay timing. ### Claim 18 A method of automatically optimizing the cardiovascular responsiveness of a patient for the patient's condition through controlled application of electrical stimulation of nerves emanating from baroreceptors of said patient comprising: providing electrical stimulation to said nerves of sufficient intensity and duration so as to reduce neurohormonal activation and induce peripheral blood vessel dilation and a drop in heart rate, determining the responsiveness of the patient's body to said stimulation by sensing a feedback parameter of patient's responsiveness indicating altered cardiovascular function; and adjusting said electrical stimulation provided to the nerves based on said feedback and an optimization algorithm until the patient's cardiovascular system is optimized for his/her condition, sensing activity of said patient using an activity sensor, and if said activity sensor indicates periods of activity, suspending or lowering intensity of said electrical stimulation until a period of time after the sensed activity has ceased. ### Claim 19 (depends on 18) A method as set forth in claim 18 wherein when the optimization algorithm is informed of overshoot in the drop in heart rate and/or peripheral vascular resistance responding by reducing the stimulation of the nerves arising from the baroreceptors. ### Claim 20 (depends on 19) A method as set forth in claim 19, wherein if overshoot of drop in heart rate passes a predetermined threshold, pacing the heart to maintain a predetermined heart rate. ### Claim 21 A method of controlled application of electrical stimulation of nerves emanating from baroreceptors of said patient comprising: providing electrical stimulation to said nerves of sufficient intensity and duration so as to reduce neurohormonal activation and induce peripheral blood vessel dilation and a drop in heart rate, sensing activity of said patient using an activity sensor, and if said activity sensor indicates periods of activity, suspending or lowering intensity of said electrical stimulation until a period of time after the sensed activity has ceased.